Crinetics (CRNX) PT Lowered to $95 at Citizens After Q1 Results
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Crinetics (NASDAQ: CRNX) to $95.00 (from $97.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
